Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 451

1.

Persistent activation of STAT3 by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.

Punjabi AS, Carroll PA, Chen L, Lagunoff M.

J Virol. 2007 Mar;81(5):2449-58. Epub 2006 Dec 6.

2.
3.

Ets-1 is required for the activation of VEGFR3 during latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.

Gutierrez KD, Morris VA, Wu D, Barcy S, Lagunoff M.

J Virol. 2013 Jun;87(12):6758-68. doi: 10.1128/JVI.03241-12. Epub 2013 Apr 3. Erratum in: J Virol. 2017 Nov 14;91(23 ):.

4.

The KSHV viral IL-6 homolog is sufficient to induce blood to lymphatic endothelial cell differentiation.

Morris VA, Punjabi AS, Wells RC, Wittkopp CJ, Vart R, Lagunoff M.

Virology. 2012 Jul 5;428(2):112-20. doi: 10.1016/j.virol.2012.03.013. Epub 2012 Apr 21.

5.
6.

Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors.

Carroll PA, Kenerson HL, Yeung RS, Lagunoff M.

J Virol. 2006 Nov;80(21):10802-12. Epub 2006 Sep 6.

7.

Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo.

An FQ, Folarin HM, Compitello N, Roth J, Gerson SL, McCrae KR, Fakhari FD, Dittmer DP, Renne R.

J Virol. 2006 May;80(10):4833-46.

8.

Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells.

Purushothaman P, Thakker S, Verma SC.

J Virol. 2015 Mar;89(6):3093-111. doi: 10.1128/JVI.02507-14. Epub 2014 Dec 31.

9.
10.

Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies.

Paul AG, Chandran B, Sharma-Walia N.

Transl Res. 2013 Aug;162(2):77-92. doi: 10.1016/j.trsl.2013.03.004. Epub 2013 Apr 6. Review.

PMID:
23567332
12.

Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease.

Abe Y, Matsubara D, Gatanaga H, Oka S, Kimura S, Sasao Y, Saitoh K, Fujii T, Sato Y, Sata T, Katano H.

Pathol Int. 2006 Oct;56(10):617-24.

PMID:
16984619
14.

The contribution of systems biology and reverse genetics to the understanding of Kaposi's sarcoma-associated herpesvirus pathogenesis in endothelial cells.

Stürzl M, Konrad A, Alkharsah KR, Jochmann R, Thurau M, Marquardt G, Schulz TF.

Thromb Haemost. 2009 Dec;102(6):1117-34. doi: 10.1160/TH09-07-0472. Review.

PMID:
19967142
15.
16.

Immortalization of primary endothelial cells by the K1 protein of Kaposi's sarcoma-associated herpesvirus.

Wang L, Dittmer DP, Tomlinson CC, Fakhari FD, Damania B.

Cancer Res. 2006 Apr 1;66(7):3658-66.

17.

Modulation of Kaposi's sarcoma-associated herpesvirus interleukin-6 function by hypoxia-upregulated protein 1.

Giffin L, Yan F, Ben Major M, Damania B.

J Virol. 2014 Aug;88(16):9429-41. doi: 10.1128/JVI.00511-14. Epub 2014 Jun 11. Erratum in: J Virol. 2014 Nov;88(21):12932.

18.

Cyclooxygenase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression.

Sharma-Walia N, Raghu H, Sadagopan S, Sivakumar R, Veettil MV, Naranatt PP, Smith MM, Chandran B.

J Virol. 2006 Jul;80(13):6534-52.

19.

STAT3 Regulates Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus.

King CA, Li X, Barbachano-Guerrero A, Bhaduri-McIntosh S.

J Virol. 2015 Nov;89(22):11347-55. doi: 10.1128/JVI.02008-15. Epub 2015 Sep 2.

20.

The gammaherpesviruses Kaposi's sarcoma-associated herpesvirus and murine gammaherpesvirus 68 modulate the Toll-like receptor-induced proinflammatory cytokine response.

Bussey KA, Reimer E, Todt H, Denker B, Gallo A, Konrad A, Ottinger M, Adler H, Stürzl M, Brune W, Brinkmann MM.

J Virol. 2014 Aug;88(16):9245-59. doi: 10.1128/JVI.00841-14. Epub 2014 Jun 4.

Supplemental Content

Support Center